Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.
Issifou YayaPerrine RouxFabienne MarcellinLinda WittkopLaure EsterleBruno SpireStéphanie DominguezBoni Armand ElegbeLionel PirothPhilippe SogniDominique Salmon-CeronMaria Patrizia Carrierinull nullPublished in: PloS one (2018)
It is possible that a majority of patients who had socio-economic problems and/or a history of drug injection and/or a non-advanced disease stage were already treated for HCV in the PEG-IFN era. Today, patients with unstable housing conditions are prescribed DAA less frequently than other populations. As HCV treatment is prevention, improving access to DAA remains a major clinical and public health strategy, in particular for individuals with high-risk behaviors.
Keyphrases
- hepatitis c virus
- public health
- human immunodeficiency virus
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- antiretroviral therapy
- immune response
- mental health
- peritoneal dialysis
- hiv positive
- hiv infected
- drug delivery
- emergency department
- hiv aids
- mental illness
- electronic health record